{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:02:06Z","timestamp":1780048926808,"version":"3.53.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,29]]},"DOI":"10.7759\/cureus.109861","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:14:54Z","timestamp":1780046094000},"source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic-Induced Manic Episodes: Clinical Recognition, Mechanistic Pathways, and Management"],"prefix":"10.7759","author":[{"given":"Enoch Chi Ngai","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Eung Danforn","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Association, Washington, DC; 2013. 10.1176\/appi.books.9780890425596"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770350059005","article-title":"Secondary mania: manic syndromes associated with antecedent physical illness or drugs","volume":"35","author":"Krauthammer C","year":"1978","unstructured":"Krauthammer C, Klerman GL. Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Arch Gen Psychiatry. 1978, 35:1333-9. 10.1001\/archpsyc.1978.01770350059005","journal-title":"Arch Gen Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0498-z","article-title":"Neuropsychiatric effects of antimicrobial agents","volume":"37","author":"Zareifopoulos N","year":"2017","unstructured":"Zareifopoulos N, Panayiotakopoulos G. Neuropsychiatric effects of antimicrobial agents. Clin Drug Investig. 2017, 37:423-37. 10.1007\/s40261-017-0498-z","journal-title":"Clin Drug Investig"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200202000-00012","article-title":"Antimicrobial-induced mania (antibiomania): a review of spontaneous reports","volume":"22","author":"Abouesh A","year":"2002","unstructured":"Abouesh A, Stone C, Hobbs WR. Antimicrobial-induced mania (antibiomania): a review of spontaneous reports. J Clin Psychopharmacol. 2002, 22:71-81. 10.1097\/00004714-200202000-00012","journal-title":"J Clin Psychopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.05.029","article-title":"Antibiotics and mania: a systematic review","volume":"219","author":"Lambrichts S","year":"2017","unstructured":"Lambrichts S, Van Oudenhove L, Sienaert P. Antibiotics and mania: a systematic review. J Affect Disord. 2017, 219:149-56. 10.1016\/j.jad.2017.05.029","journal-title":"J Affect Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000002089","article-title":"Antibiomania. A systematic review of clarithromycin-associated manic episodes","volume":"46","author":"Markovi\u0107 T","year":"2026","unstructured":"Markovi\u0107 T, Todorovi\u0107 A, Stojkovi\u0107 M, Popovi\u0107 S, Baski\u0107 D, Mati\u0107 S. Antibiomania. A systematic review of clarithromycin-associated manic episodes. J Clin Psychopharmacol. 2026, 46:82-92. 10.1097\/JCP.0000000000002089","journal-title":"J Clin Psychopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/10398562251370946","article-title":"Antibiomania: an update","volume":"33","author":"Parker G","year":"2025","unstructured":"Parker G, Russo N. Antibiomania: an update. Australas Psychiatry. 2025, 33:797-9. 10.1177\/10398562251370946","journal-title":"Australas Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12416","article-title":"Individuals hospitalized with acute mania have increased exposure to antimicrobial medications","volume":"18","author":"Yolken R","year":"2016","unstructured":"Yolken R, Adamos M, Katsafanas E, et al.. Individuals hospitalized with acute mania have increased exposure to antimicrobial medications. Bipolar Disord. 2016, 18:404-9. 10.1111\/bdi.12416","journal-title":"Bipolar Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.79671","article-title":"Beyond infection: a case of doxycycline-induced mania and prolonged neuropsychiatric disturbance","volume":"17","author":"Lim EC","year":"2025","unstructured":"Lim EC, Cheng NC, Lim CE. Beyond infection: a case of doxycycline-induced mania and prolonged neuropsychiatric disturbance. Cureus. 2025, 17:e79671. 10.7759\/cureus.79671","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1435923","article-title":"Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database","volume":"15","author":"Xie WL","year":"2024","unstructured":"Xie WL, Ge ML, Chen D, Chen GQ, Mei YX, Lai YJ. Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database. Front Pharmacol. 2024, 15:1435923. 10.3389\/fphar.2024.1435923","journal-title":"Front Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-021-03397-7","article-title":"Antibiomania: a case report of clarithromycin and amoxicillin-clavulanic acid induced manic episodes separately","volume":"21","author":"Meszaros EP","year":"2021","unstructured":"Meszaros EP, Stancu C, Costanza A, Besson M, Sarasin F, Bondolfi G, Ambrosetti J. Antibiomania: a case report of clarithromycin and amoxicillin-clavulanic acid induced manic episodes separately. BMC Psychiatry. 2021, 21:399. 10.1186\/s12888-021-03397-7","journal-title":"BMC Psychiatry"},{"key":"ref12","unstructured":"U.S. Food and Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. (2018). https.\/\/web.archive.org\/web\/20251214152856\/https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-reinforces-safe...."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.13272","article-title":"Isoniazid-induced mania and the history of antidepressant drugs: case report and literature review","volume":"25","author":"Samouco AI","year":"2023","unstructured":"Samouco AI, Alves SP. Isoniazid-induced mania and the history of antidepressant drugs: case report and literature review. Bipolar Disord. 2023, 25:84-7. 10.1111\/bdi.13272","journal-title":"Bipolar Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00134.2016","article-title":"Clarithromycin increases neuronal excitability in CA3 pyramidal neurons through a reduction in GABAergic signaling","volume":"117","author":"Bichler EK","year":"2017","unstructured":"Bichler EK, Elder CC, Garc\u00eda PS. Clarithromycin increases neuronal excitability in CA3 pyramidal neurons through a reduction in GABAergic signaling. J Neurophysiol. 2017, 117:93-103. 10.1152\/jn.00134.2016","journal-title":"J Neurophysiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/31.4.457","article-title":"Antagonism of GABAA receptors by 4-quinolones","volume":"31","author":"Halliwell RF","year":"1993","unstructured":"Halliwell RF, Davey PG, Lambert JJ. Antagonism of GABAA receptors by 4-quinolones. J Antimicrob Chemother. 1993, 31:457-62. 10.1093\/jac\/31.4.457","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.7.1831","article-title":"Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model","volume":"42","author":"Schmuck G","year":"1998","unstructured":"Schmuck G, Sch\u00fcrmann A, Schl\u00fcter G. Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model. Antimicrob Agents Chemother. 1998, 42:1831-6. 10.1128\/AAC.42.7.1831","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200038010-00003","article-title":"Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition","volume":"38","author":"Dresser GK","year":"2000","unstructured":"Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet. 2000, 38:41-57. 10.2165\/00003088-200038010-00003","journal-title":"Clin Pharmacokinet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006055","article-title":"Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in mammalian cells","volume":"5","author":"Kalghatgi S","year":"2013","unstructured":"Kalghatgi S, Spina CS, Costello JC, et al.. Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in mammalian cells. Sci Transl Med. 2013, 5:192ra85. 10.1126\/scitranslmed.3006055","journal-title":"Sci Transl Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-008-9865-8","article-title":"Mitochondrial dysfunction and psychiatric disorders","volume":"34","author":"Rezin GT","year":"2009","unstructured":"Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL. Mitochondrial dysfunction and psychiatric disorders. Neurochem Res. 2009, 34:1021-9. 10.1007\/s11064-008-9865-8","journal-title":"Neurochem Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.572912","article-title":"Antibiotics as major disruptors of gut microbiota","volume":"10","author":"Ramirez J","year":"2020","unstructured":"Ramirez J, Guarner F, Bustos Fernandez L, Maruy A, Sdepanian VL, Cohen H. Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol. 2020, 10:572912. 10.3389\/fcimb.2020.572912","journal-title":"Front Cell Infect Microbiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035677","article-title":"Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review","volume":"10","author":"Elvers KT","year":"2020","unstructured":"Elvers KT, Wilson VJ, Hammond A, Duncan L, Huntley AL, Hay AD, van der Werf ET. Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review. BMJ Open. 2020, 10:e035677. 10.1136\/bmjopen-2019-035677","journal-title":"BMJ Open"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan JF","year":"2019","unstructured":"Cryan JF, O'Riordan KJ, Cowan CS, et al.. The microbiota-gut-brain axis. Physiol Rev. 2019, 99:1877-2013. 10.1152\/physrev.00018.2018","journal-title":"Physiol Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/498070-antibiotic-induced-manic-episodes-clinical-recognition-mechanistic-pathways-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:14:56Z","timestamp":1780046096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/498070-antibiotic-induced-manic-episodes-clinical-recognition-mechanistic-pathways-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.109861","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}